Antigens of Leishmania parasites
US4992273A · kind A · utility
11Cited by
0References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 31, 1986 |
| Grant date | Feb 12, 1991 |
| Priority date | — |
| Expiry date | Jul 31, 2006 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns hybridomes producing anti-Leishmania monoclonal antibodies which are characterized by their capacity to inhibit the infection of sarcomatous cells by the promastigote forms of one or more species of Leishmania, when the sarcomatous cells are placed in contact with the said promastigote forms pre-incubated with these monoclonal antibodies under conditions which, in the absence of the said monoclonal antibodies, would lead to an elevated parasitemia in the said cells. These monoclonal antibodies and the proteins of the parasites that they recognize may be used in the operations of leishmanioses detections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.